NECTAR Study: Neoadjuvant Toripalimab + 9MW2821 for Local UTUC

Clinical trial NCT07412171 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07412171
Sponsor: Peking University Third Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Upper Tract Urothelial Carcinoma

Start date: 2026-02-01
Primary completion: 2028-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.